Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial

The B-cell lymphoma-2 (Bcl-2) family of proteins play a crucial role in multiple myeloma (MM), contributing to lacking apoptosis which is a hallmark of the disease. This makes the Bcl-2 proteins interesting targets for therapeutic peptide vaccination. We report a phase I trial of therapeutic vaccina...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stem Cell Investig
Main Authors: Jørgensen, Nicolai Grønne, Ahmad, Shamaila Munir, Abildgaard, Niels, Straten, Per Thor, Svane, Inge Marie, Andersen, Mads Hald, Knudsen, Lene Meldgaard
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2016
Assuntos:
Short Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5222710/
https://ncbi.nlm.nih.gov/pubmed/28078275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/sci.2016.11.09
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados